MedTrace Logo

Evaluation of Heart Status in Patients of Beta Thalassemia Using Echocardiogram

NCT04929574 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2021-06-18

No results posted yet for this study

Summary

Heart failure from myocardial iron deposition is a severe complication for patients with transfusion-dependent beta thalassemia . Increased cardiac iron content impacts the contractility of cardiomyocytes and can also lead to myocarditis, pericarditis, and arrhythmias. The severity of cardiac dysfunction depends on the amount of iron deposited in the myocardium.Echocardiogram is used as noninvasive method to observe heart status. The objective of this study is to evaluate the heart status in patients of Beta Thalassemia from southern China.

Conditions

  • Beta Thalassemia

Interventions

DIAGNOSTIC_TEST

Echocardiogram and Hematological Analysis

Echocardiogram and Hematological Analysis

Sponsors & Collaborators

  • ZhuHai Hospital

    collaborator OTHER

  • Shenzhen Children's Hospital

    collaborator OTHER_GOV

  • Shenzhen Second People's Hospital

    collaborator OTHER

  • Jiangmen Maternity and Child Health Care Hospital

    collaborator UNKNOWN

  • Yongzhou Maternity and Child Health Hospital

    collaborator UNKNOWN

  • Nanfang Hospital, Southern Medical University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-01
Primary Completion
2024-07-01
Completion
2025-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04929574 on ClinicalTrials.gov